Home » Topics » BioWorld Science

BioWorld Science
RSS

Modest data for PI3K inhibitor taselisib in breast cancer

June 11, 2018

Bayer closes its acquisition of Monsanto

June 11, 2018

NOSO-502: a new antibacterial drug candidate active against carbapenem-resistant Enterobacteriaceae

June 11, 2018

FDA approves Rituxan for moderate to severe pemphigus vulgaris

June 11, 2018

FDA approves IND application for clinical study of RK-01

June 11, 2018

Updated interim data from phase I/II study of lumasiran for primary hyperoxaluria type 1

June 8, 2018

Minesapride shows clinical efficacy in irritable bowel syndrome with constipation

June 8, 2018

Luye Pharma and Elpis expand collaboration in immuno-oncology

June 8, 2018

First celiac disease model with a humanized immune system reported

June 8, 2018

MyoKardia opens phase III study of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy

June 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...